Navigation Links
GeoVax to Present at the BIO CEO & Investor Conference 2009
Date:1/28/2009

ATLANTA, Jan. 28 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that Robert McNally, Ph.D., Chief Executive Officer and President, will present a corporate update at the Eleventh Annual BIO CEO & Investor Conference 2009, held at the Waldorf-Astoria Hotel, in New York, on February 9-10, 2009.

The BIO CEO & Investor Conference is the preeminent gathering of cutting edge biotechnology companies, represented by senior executives, presenting their achievements to institutional investors, industry analysts and portfolio senior executives. Presenting companies were selected through a competitive screening process with a focus on their potential to deliver near-term clinical accomplishments in areas of unmet medical need. The expected attendance at the conference will include representatives from nearly 80 investment firms with a specific interest in life science companies.

Dr. McNally will present an overview of GeoVax's vaccine technology and will report the latest progress on the Company's Phase 2a preventative human vaccine trial and plans for upcoming therapeutic human vaccine trials. Dr. McNally also plans to meet one-on-one with current and prospective GeoVax investors, analysts, investment bankers and other potential Company partners.

"Having met significant milestones entering Phase 2a human trials with our highly promising HIV-1/AIDS vaccines and with our plans to launch our therapeutic human trials in the near future, the time has arrived for the Biotech sector and its respective investment audience to learn about our progress. We feel privileged to be among a select group of biotech companies showcasing our technologies to an elite group of interested investment
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
2. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
3. GeoVax Further Strengthens Management Team
4. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
5. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
6. GeoVax Presents Data at AIDS Vaccine 2008 Conference
7. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
8. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
9. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
10. Avicena Group to Present at Noble Financial Conference
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... 2014 UMBC’s Biotechnology Graduate Programs’ ... October 21, 2014, from 12:00 to 1:00 p.m. EDT. ... innovative curriculum and practice-oriented instruction, designed for working professionals. ... help advance their career in the biotechnology industry. , ... , About UMBC’s Biotechnology Graduate Programs, UMBC offers ...
(Date:9/12/2014)... Arthur Kay , the 23-year-old British founder of environmentally ... Challenge 2014. The jury, chaired by Ellen MacArthur ... final in Amsterdam to realize ... uses a patented process to upcycle waste coffee grounds ... used for powering buildings and transport systems. Bio-bean is ...
(Date:9/12/2014)... Sandia Biotech, Inc. announced today that the ... (STC) for a technology developed by researchers at the ... and Queen Mary University of London in London, England. ... Antibody Technology Platform (RFAP) was developed by Dr. Ravi ... Angray Kang from Queen Mary’s Department of Molecular Cell ...
(Date:9/11/2014)... thick sheet of carbon, can be randomly decorated with ... that could have a significant impact on the chemical, ... provide an ultra-strong, non-corrosive coating for a wide range ... be used to paint various surfaces ranging from glass ... chemical treatment, the resulting coatings behave like graphite in ...
Breaking Biology Technology:UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2Green Startup Bio-Bean Wins $680,000 in Postcode Lottery Green Challenge 2Green Startup Bio-Bean Wins $680,000 in Postcode Lottery Green Challenge 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4Graphene paints a corrosion-free future 2
... Sinovac Biotech Ltd. (Amex:,SVA), a leading provider of ... for Disease Control and Prevention (CDC) ordered 257,100,doses ... by,Sinovac. On the same day, the Gansu CDC ... and hepatitis B vaccine manufactured by Sinovac. The,vaccine ...
... NEW ORLEANS, La. A promising new technique has ... positron emission tomography (PET) imaging of new cells ... SNM,s 55th Annual Meeting. The new technique, which ... genesor markers that signal cells of interest for ...
... ST. PAUL, Minn. and SAN DIEGO, June ... GPRO ) announced today that 3M has,discontinued ... tests,for healthcare-associated infections (HCAIs)., The companies, ... future,marketing collaboration in this area, said the ...
Cached Biology Technology:Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas 2Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas 3New molecular imaging techniques may lead to advances in disease treatment 23M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections 23M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections 3
(Date:9/15/2014)... much as 170 tons, the blue whale is the largest ... thing ever seen on Earth. So there,s no way it ... which measure millimeters in length and tip the scales at ... fast, says L. Mahadevan, the Lola England de Valpine Professor ... Physics. , Using simple hydrodynamics, a team of researchers ...
(Date:9/15/2014)... single protein may tip the balance between ridding the ... infection, according to a report appearing in ... B and C viruses cause chronic infections in roughly ... for developing liver diseases including cirrhosis and cancer. A ... immune cells called CD8 + T cells. The ...
(Date:9/15/2014)... 2014  GENiSYSS, a biotechnology firm located in ... public launch of their website, genisyss.com .  ... room temperature, long-term storage of DNA and associated ... personal storage of DNA practical and readily available. ... Photo - http://photos.prnewswire.com/prnh/20140912/145665 ...
Breaking Biology News(10 mins):The science behind swimming 2The science behind swimming 3GENiSYSS Launches Website about Easy, Inexpensive Home DNA Storage for Everyone 2
... (April 27, 2009) In an in vitro study, led ... researchers discovered how a protein called SUMO (Small Ubiquitin-related ... of chromatin to regulate expression of genes. Chromatin is ... up chromosomes. The interaction between SUMO and the enzyme ...
... macrophages, immune cells that can engulf and poison bacteria ... A new study from the University of Illinois disproves ... PLoS ONE , shows that macrophages focus their most ... targets outside the cytoplasm. Macrophages are voracious eaters ...
... 27, 2009 Landfilled waste decomposes in the ... of methane. Landfills are classified as the second-largest ... landfill gas contains numerous non-methane hydrocarbons that are ... through biochemical reactions during waste degradation. Microbial ...
Cached Biology News:SUMO protein guides chromatin remodeler to suppress genes 2New study overturns orthodoxy on how macrophages kill bacteria 2New study overturns orthodoxy on how macrophages kill bacteria 3Landfill cover soil methane oxidation underestimated 2
Antibeta-lactoglobulin monoclonal antibody(CD-2)...
MAb to Vasopressin Preservative: NaN3...
... Anti-AP-2 α, clone 8G8/5 GenBank Accession ... made human AP-2alpha/gamma fusion protein corresponding to ... 278-450 of human AP-2γ Formulation: 0.1M Tris-glycine, ... before the addition of glycerol to 30% ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
Biology Products: